Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
For many individuals with autism and their families, their first experience with the Waisman Center may be through the center’s Autism and Developmental Disabilities (A&DD) Clinic. The A&DD Clinic’s primary focus is providing diagnostic evaluations and follow-up care for to individuals suspected of having autism or other developmental disabilities.
After an extensive national search, Chris Bartley was recently selected as the new managing director of Waisman Biomanufacturing (WB). Bartley most recently served as the facility’s interim director.
Epigenetics – the study of how environment can change and affect how genes function – was a new field for Phu Duong, PhD.
Community TIES (Training, Intervention, and Evaluation Services) is a UW-Waisman Center behavioral support program that serves residents of Dane County with intellectual and developmental disabilities and their families.
The Waisman Center community is saddened by the passing of Don Anderson, MSSW, in March 3, 2023. Anderson was a clinical assistant professor in the UW-Madison Sandra Rosenbaum School of Social Work and the Waisman Center from 1974 to 2004.
The Centers for Disease Control and Prevention published the most recent numbers from the Autism and Developmental Disabilities Monitoring Network (ADDM) that shows an increase in autism prevalence and shifting demographics for diagnosis. The CDC found that 1 in 36 (2.8%) 8-year-old kids were diagnosed with autism which is an increase from the 1 in …
For Women’s History Month we are celebrating all of the women of Waisman who are advancing knowledge of intellectual and developmental disabilities and providing cutting-edge clinical care.
Since 1978, more than 2.5 million Wisconsin babies have been touched by the University of Wisconsin–Madison within their first few days of being born.
Retinal cells grown from stem cells can reach out and connect with neighbors, according to a new UW study, completing a “handshake” that may show the cells are ready for trials in humans with degenerative eye disorders.
In 2001, newborn screening of Hmong babies had an alarming number of positive results for an enzyme deficiency called MBADD.
